Release Date: 05/05/22 13:10 Summary: Units on Issue Disclosure - Apr 2022 Price Sensitive: No Download Document 115.74KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%